Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesChetan Bettegowda, Jon Weingart, Mark Sausen et al.|Science Translational Medicine|2014Cited by 5.1k
UALCAN: An update to the integrated cancer data analysis platformDarshan S. Chandrashekar, Sooryanarayana Varambally, Santhosh Kumar Karthikeyan et al.|Neoplasia|2022Cited by 2.5k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalPatrick Killela, Hai Yan, Zachary J. Reitman et al.|Proceedings of the National Academy of Sciences|2013Cited by 1.4k
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.Edward M. Schaeffer, Deborah A. Freedman-Cass, Neil Desai et al.|PubMed|2022Cited by 172
Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancerAlcides Chaux, George J. Netto|Modern Pathology|2012Cited by 132